 Vasodilator Agents
"Vasodilator Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to cause dilation of the blood vessels.
| Descriptor ID |
D014665
|
| MeSH Number(s) |
D27.505.954.411.918
|
| Concept/Terms |
Vasodilator Agents- Vasodilator Agents
- Agents, Vasodilator
- Vasodilators
- Vasorelaxants
- Vasodilator Drugs
- Drugs, Vasodilator
|
Below are MeSH descriptors whose meaning is more general than "Vasodilator Agents".
Below are MeSH descriptors whose meaning is more specific than "Vasodilator Agents".
This graph shows the total number of publications written about "Vasodilator Agents" by people in this website by year, and whether "Vasodilator Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 | | 1996 | 3 | 1 | 4 | | 1997 | 1 | 1 | 2 | | 1998 | 4 | 1 | 5 | | 1999 | 0 | 5 | 5 | | 2000 | 0 | 1 | 1 | | 2001 | 2 | 4 | 6 | | 2002 | 1 | 6 | 7 | | 2003 | 7 | 1 | 8 | | 2004 | 1 | 2 | 3 | | 2005 | 1 | 2 | 3 | | 2006 | 4 | 2 | 6 | | 2007 | 3 | 3 | 6 | | 2008 | 5 | 2 | 7 | | 2009 | 4 | 8 | 12 | | 2010 | 4 | 7 | 11 | | 2011 | 6 | 6 | 12 | | 2012 | 5 | 6 | 11 | | 2013 | 5 | 6 | 11 | | 2014 | 2 | 6 | 8 | | 2015 | 6 | 1 | 7 | | 2016 | 5 | 7 | 12 | | 2017 | 2 | 8 | 10 | | 2018 | 1 | 2 | 3 | | 2019 | 2 | 2 | 4 | | 2020 | 0 | 1 | 1 | | 2021 | 1 | 6 | 7 | | 2022 | 0 | 4 | 4 | | 2023 | 1 | 4 | 5 | | 2024 | 0 | 1 | 1 | | 2025 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vasodilator Agents" by people in Profiles.
-
Garcia VP, Fandl HK, Wegerson KN, Berry AR, Ruzzene ST, Greiner JJ, Stockelman KA, Dow CA, Park AJ, Stauffer BL, DeSouza CA. Elevated circulating endothelial cell-derived microvesicles: a biomarker of endothelial vasomotor dysfunction in adults with obesity. J Appl Physiol (1985). 2025 May 01; 138(5):1143-1149.
-
Bernaldo de Quir?s Y, Mahoney SA, VanDongen NS, Greenberg NT, Venkatasubramanian R, Saavedra P, Bossart G, Brunt VE, Clayton ZS, Fern?ndez A, Seals DR. The bottlenose dolphin (Tursiops truncatus): a novel model for studying healthy arterial aging. Am J Physiol Heart Circ Physiol. 2024 Sep 01; 327(3):H660-H665.
-
Lakshminrusimha S, Abman SH. Oxygen Targets in Neonatal Pulmonary Hypertension: Individualized, "Precision-Medicine" Approach. Clin Perinatol. 2024 03; 51(1):77-94.
-
Richey RE, Ruiz YI, Cope HL, Moore AM, Walsh MA, Garfield TC, Olivencia-Yurvati AH, Romero SA. Cyclooxygenase inhibition does not blunt thermal hyperemia in skeletal muscle of humans. J Appl Physiol (1985). 2024 Jan 01; 136(1):151-157.
-
Self WH, Shotwell MS, Gibbs KW, de Wit M, Files DC, Harkins M, Hudock KM, Merck LH, Moskowitz A, Apodaca KD, Barksdale A, Safdar B, Javaheri A, Sturek JM, Schrager H, Iovine N, Tiffany B, Douglas IS, Levitt J, Busse LW, Ginde AA, Brown SM, Hager DN, Boyle K, Duggal A, Khan A, Lanspa M, Chen P, Puskarich M, Vonderhaar D, Venkateshaiah L, Gentile N, Rosenberg Y, Troendle J, Bistran-Hall AJ, DeClercq J, Lavieri R, Joly MM, Orr M, Pulley J, Rice TW, Schildcrout JS, Semler MW, Wang L, Bernard GR, Collins SP. Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials. JAMA. 2023 04 11; 329(14):1170-1182.
-
Wenner MM, Welti LM, Dow CA, Greiner JJ, Stauffer BL, DeSouza CA. Aerobic exercise training reduces ET-1-mediated vasoconstriction and improves endothelium-dependent vasodilation in postmenopausal women. Am J Physiol Heart Circ Physiol. 2023 06 01; 324(6):H732-H738.
-
Zhang H, D'Alessandro A, Li M, Reisz JA, Riddle S, Muralidhar A, Bull T, Zhao L, Gerasimovskaya E, Stenmark KR. Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension. Vascul Pharmacol. 2023 04; 149:107157.
-
Cookson MW, Abman SH, Kinsella JP, Mandell EW. Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension. Semin Fetal Neonatal Med. 2022 08; 27(4):101367.
-
Rosenzweig EB, Bates A, Mullen MP, Abman SH, Austin ED, Everett A, Fineman J, Feinstein J, Hopper RK, Kinsella JP, Krishnan US, Lu M, Mandl KD, Raj JU, Varghese N, Yung D, Handler SS, Sleeper LA. Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension. Ann Am Thorac Soc. 2022 06; 19(6):1000-1012.
-
Tooker BC, Kandel SE, Work HM, Lampe JN. Pseudomonas aeruginosa cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE. J Biol Chem. 2022 03; 298(3):101629.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|